Infección y Inmunidad (INIM)

INFECCIÓN, INMUNIDAD Y MEDIO AMBIENTE
OBJECTIUS

El grupo Infección y Inmunidad (INIM) es un grupo de investigación especializado en el estudio de enfermedades infecciosas, centrando su mayor actividad en el ámbito de la inmunopatogenia del VIH, que se trata de un fenómeno complejo y multifactorial que afecta a la función normal del sistema inmune. Los responsables del grupo son el doctor Joaquim Peraire y la doctora Anna Rull, que lideran un grupo mixto formado por investigadores clínicos y básicos

RESPONSABLES
  • Dra. Anna Rull Aixa

  • Dr. Joaquim Peraire Forner

  • Presentació
  • Líneas de investigación
  • Miembros del grupo
  • Membres del grup
  • Proyectos
  • Transferencia
  • Publicaciones
  • Difusión
  • Publicacions
  • Contacto

El grupo, creado en 1995 por los doctores Francesc Vidal, Joaquim Peraire y Consuelo Viladés, se estableció en el Hospital Universitario Joan XXIII (HJ23) de Tarragona y en la Universidad Rovira i Virgili (URV), y la Fundación Instituto de Investigación Sanitaria Pere Virgili (IISPV) se encarga de gestionar sus actividades principales. En 2022, el INIM se incorporó a la Red de Investigación sobre el SIDA (RETIC-RIS) (RD16/0025/0006) del Instituto de Salud Carlos III (ISCIII) (CB21/13/0020), y actualmente forma parte de la red nacional CIBERINFEC y está reconocido como grupo de excelencia por la Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) de la Generalitat de Cataluña.

La actividad del grupo se centra principalmente en la investigación clínica y traslacional, con un enfoque en los últimos años hacia la aplicabilidad de las ciencias ómicas en el ámbito del VIH/sida y, más recientemente, en la infección por el SARS-CoV-2. El grupo entiende la investigación biomédica y sanitaria de calidad como una actividad cooperativa, por lo que colabora con diversas instituciones nacionales e internacionales. Además, el INIM cuenta con una amplia experiencia en la formación de estudiantes de grado y posgrado, en la dirección de tesis doctorales y en la formación posdoctoral. Asimismo, los miembros del grupo también imparten actividades docentes y formativas en el ámbito académico.

Las líneas de investigación del grupo INIM se enmarcan en el ámbito de las enfermedades infecciosas, y la mayoría de ellas se centran en el VIH:

Salud global, infecciones emergentes y reemergentes.

Infección por COVID-19: epidemiología y manejo clínico, inmunopatogénesis y daño mitocondrial. VIH/sida e infecciones de transmisión sexual.

Inmunopatogénesis de la infección por el VIH.
Cura funcional: estudios inmunometabólicos en controladores de élite.
Envejecimiento y comorbilidades.
Estudios epidemiológicos y clínicos.
N
Pacientes que no responden inmunológicamente: mecanismos moleculares.
Envejecimiento y comorbilidades.
Estudios epidemiológicos y clínicos.
Nuevas estrategias de tratamiento antirretroviral: eficacia y seguridad. Estudios de toxicidad.
* Otros programas:
* Infecciones nosocomiales.
* Resistencias a los antimicrobianos.
* Bacteriemia y endocarditis.
* Otros

  • Title:  PI23/00080: Relación entre alteraciones en el metabolismo de los lípidos y la función mitocondrial en la pobre recuperación inmunológica (LIMITOINR). [Proyecto de I+D+I en Salud]

    Funding entity: Instituto de Salud Carlos III (ISCIII).

    Duration: 2024-2026

    Principal Investigator:  Anna Rull Aixa

  • Title:  PI20/00326: Papel del microbioma intestinal en la estabilidad y función de los lípidos y las lipoproteínas: recuperación inmune y progresión de la enfermedad por infección VIH (LipoHIV).

    Funding entity: Instituto de Salud Carlos III (ISCIII).

    Duration: 2021-2025

    Principal Investigator:  Anna Rull Aixa

    Team member: Veloso Estebán, Sergio; Viladés Laborda, Consuelo Gloria; Masip Morcillo, Jenifer; López Dupla, Jesús Miguel.

  • Title:  PI19/01337: Perfil ómico asociado con la progresión de la infección por VIH: En busca de nuevos biomarcadores y de nuevas dianas terapéuticas para lograr la curación funcional del VIH.

    Funding entity: Instituto de Salud Carlos III (ISCIII).

    Duration: 2020-2024

    Principal Investigator:  Peraire Forner, Joaquim

    Team member: Veloso Estebán, Sergio; Viladés Laborda, Consuelo Gloria; Rodríguez Gallego, Esther; Vidal Marsal, Francisco.

  • Title: A MULTI-OMIC SUBSTUDY FOR THE CLINICAL TRIAL “dtg/3tc vs. bic/ftc/taf maintenance therapy in people living with HIV: an open-label randomized clinical trial.

    Funding entity: Fundación SEIMC-GeSIDA.

    Duration: 2021-2025

    Principal Investigator:  Anna Rull Aixa / Francesc Vidal Marsal / Joaquim Peraire Forner

  • Title:  Role of the gut microbiome in lipid and lipoprotein function: Immune recovery and HIV disease progression (LipoHIV). PI20/00326

    Funding entity: Instituto de Salud Carlos III (ISCIII).

    Duration: 2022-2024

    Principal Investigator:  Anna Rull Aixa

  • Title:  Omics profile associated with HIV disease progression: looking for new biomarkers and for new therapeutic targets to achieve HIV functional cure.

    Funding entity: Fondo de Investigación Sanitaria. Instituto de Salud Carlos III (ISCIII).

    Duration: 2020-2023

    Principal Investigator:  Francesc Vidal Marsal

    Collaboration. co-IP: Joaquim Peraire Forner.

  • Title:  2019/IISPV/05, Evaluation of sTWEAK/Fn14/CD163 axis as potential predictive biomarkers of immunological recovery and disease progression in HIV-infected patients under virological suppression.

    Funding entity:  Institut d’Investigació Sanitària Pere Virgili (IISPV).

    Duration: 2020-2021

    Principal Investigator:  Anna Rull Aixa

  • Title:  Circulating and cellular prognostic biomarkers for COVID19 progression in patient with SARS-CoV-2 infection using multi omic science.

    Funding entity:  Generalitat de Catalunya

    Duration: 2020

    Principal Investigator:  Francesc Vidal Marsal

  • Title:  EUIN2017-89297, Role of the gut microbiome in lipoprotein function and stability: immune recovery and HIV disease progression

    Funding entity:  Ministerio de Economía, Industria y Competitividad.

    Duration: 2018-2019

    Principal Investigator: Anna Rull Aixa

    Guías clínicas

  • (Patente)

    Títol: Methods for the prognosis of HIV-Infected subjects

    Reference number: EP18382669.2 – PCT/EP2019/074906

    Inventors: Rodriguez Gallego, Esther; Rull Aixa, Anna; Peraire Forner, Joaquim; Viladés Laborda, Consuelo; Vidal Marsal, Francesc; Alba Elvira, Veronica; Ruiz-Mateos Carmona, Eziquiel; López Cortés, Luis Fernando; Tarancón Díez, Laura.

    Registration date: 2019

  • Mensa J, et al (Vidal F). Guia de Terapéutica Antimicrobiana 2022. Editorial Antares, Barcelona 2022. ISBN: 978-84-88825-31-5.

  • Mensa J, et al (Vidal F). Guia de Terapéutica Antimicrobiana 2021. Editorial Antares, Barcelona 2021. ISBN: 978-84-88825-33-9.

  • Mallolas J, et al (Vidal F). Guia Práctica del SIDA. Clínica, Diagnóstico y Tratamiento, 16ª Ed. Editorial Antares, Barcelona 2021. ISBN: 978-84-88825-30-8.

  • Mensa J, et al (Vidal F). Guia de Terapéutica Antimicrobiana 2020. Editorial Antares, Barcelona 2020. ISBN: 978-84-88825-29-2.

  • Panel de expertos de GeSIDA y Plan Nacional del SIDA: Martinez E, Arribas JR, Polo R, Gonzalez J, Palacios R, Berenguer J, Bernal E, Blanco JR, Curran A, de Mendoza C, Domingo P, Dueñas C, Estrada V, Galindo MJ, González-Cordón A, Gutiérrez F, Iribarren JA, Imaz A, Mariño A, Miralles C, Miró JM, Montes ML, Moreno S, Paredes R, Perez-Molina JA, Pérez-Elias MJ, Pulido F, Ribera E, Rivero A, Rubio R, Ryan P, Sanchez-Conde M, Sanz J, Sanz J, Serrano S, Suarez I, Torralba M, Tuset M, Velasco I, Viciana P, Vidal F, von Vichmann M. Documento de consenso de GeSIDA / Plan Nacional del Sida respecto al tratamiento antiretroviral en adultos infectados por el VIH. Ministerio de Sanidad, Gobierno de España, 2020.

  • Mensa J; Soriano A; García-Sánchez JE; Letang E; López-Suñé E; Marco F, Llinares P. Guía de Terapéutica Antimicrobiana 2019. (Spain): Antares Editorial, 2019. ISBN-13: 9788488825292.

  • Mensa J, et al (Vidal F). Guia de Terapéutica Antimicrobiana 2019. Editorial Antares, Barcelona 2019. ISBN: 978-84-88825-26-1.

  • Clotet B, et al (Vidal F). Guia Práctica del SIDA. Clínica, Diagnóstico y Tratamiento, 15ª Ed. Editorial Antares, Barcelona 2019. ISBN: 978-84-88825-28-5.

  • Panel de expertos de GeSIDA y Plan Nacional del SIDA: Perez-Molina JA, Polo R, Martinez E, Gonzalez J, Lozano F, Aguirrebengoa K, Arribas JR, Berenguer J, Blanco JR, Boix V, Curran A, Domingo P, Dueñas C, Estrada V, Galindo MJ, Garcia F, Gutiérrez F, Iribarren JA, Imaz A, Knobel H, Llibre JM, Losa JE, Mariño A, Miralles C, Miró JM, Montes ML, Moreno S, Pérez-Elias MJ, Pulido F, Ribera E, Rivero A, Rubio R, Ryan P, Sanchez-Conde M, Sanz J, Sanz J, Serrano S, de la Torre J, Tuset M, Vidal F, von Vichmann M. Documento de consenso de GeSIDA / Plan Nacional del Sida respecto al tratamiento antirretroviral en adultos infectados por el VIH. Ministerio de Sanidad, Consumo y Bienestar Social, Gobierno de España, 2019.

  • Mensa J; Gatell JM; García-Sánchez JE; Letang E; López-Suñé E; Marco F. Guía de Terapéutica Antimicrobiana 2018. (Spain): Antares Editorial, 2018. ISSN-e 2255-0569.

  • Mensa J, et al (Vidal F). Guía de Terapéutica Antimicrobiana 2018. Editorial Antares, Barcelona 2018. ISBN: 978-84-88825-24-7.

    A metagenome-wide association study of HIV disease progression in HIV controllers.

    Real LM, Sáez ME, Corma A, Gonzalez A, Thorball C, Ruiz R, Jimenez MR, Gonzalez A, Gasca C, Bravo MJ, Royo JL, Perez A, Camacho MI, Gallego I, Vitalle J, Bachiller S, Gutiérrez A, idal F, Fellay J, Lichterfeld M, Ruiz E, Swiss HIV Cohort S.

    iScience. 2023. 26. (7):p. 107214-107214.

    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.

    Grillo S, Pujol M, Miró JM, López J, Euba G, Gasch O, Boix L, García MJ, Pérez MT, Gómez S, Oriol I, López LE, Pedro ML, San R, Aguado JM, Gioia F, Iftimie SM, Morata L, Jover A, García G, Loeches B, Izquierdo A, Goikoetxea AJ, Gomila A, Dietl B, Berbel D, Videla S, Hereu P, Padulles A, Pallarès N, Tebé C, Cuervo G, Carratalà J, SAFO GRP.

    Nat Med. 2023. 29. (10):p. 2518-2525.

    Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with human immunodeficiency virus in high-income countries: An international collaborative cohort study.

    Ingle SM, Miro JM, May MT, Cain LE, Schwimmer C, Zangerle R, Sambatakou H, Cazanave C, Reiss P, Brandes V, Bucher HC, Sabin C, Vidal F, Obel N, Mocroft A, Wittkop L, Monforte AD, Torti C, Mussini C, Furrer H, Konopnicki D, Teira R, Saag MS, Crane HM, Moore RD, Jacobson JM, Mathews WC, Geng EL, Eron JJ, Althoff KN, Kroch A, Lang RY, Gill MJ, Sterne J, A, Cohere ECN.

    Clin Infect Dis. 2023. 77. (1):p. 64-73.

    Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV1 infection in clinical practice.

    Suárez I, Alejos B, Hernando V, Viñuela L, García MV, Rial D, Elías MJP, Iglesias HA, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrin I, Cohort Spanish HIV AIDS Res N.

    J Antimicrob Chemother. 2023. 78. (6):p. 1423-1432.

    Fucosylated N-glycans as early biomarkers of COVID-19 severity.

    Paton B, Herrero P, Peraire J, Del Pino A, Chafino S, Martinez J, Gómez FF, Rull A, Canela N, Suarez M.

    Front Immunol. 2023. 14. p. 1204661-1204661.

    Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery.

    Sanchez A, García G, Gómez FF, López JM, Foguet E, Buzón MJ, Almirante B, Olona MM, Fernández S, Vidal F, Chafino S, Rull A, Covidomics Grp, Peraire J.

    iScience. 2023. 26. (10):p. 107948-107948.

    Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: Differential impact of antiretroviral regimens.

    Burgos J, Moreno S, Reyes J, Bruguera A, Martin R, Raventos B, Llibre JM; Imaz A, Peraire J, Orti AJ, Dalmau D, Casabona J, Miró JM, Falcó V.

    Journal of Antimicrobial Chemotherapy. 2023. 78. (1):p. 108-116.

    Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective,  cohort study.

    Brito P, Flores A, Horváth IF, Rasmussen A, Li XM, Olsson P, Vissink A, Priori R, Armagan , Hernandez G, Praprotnik S, Quartuccio L, Inanç N, Özkiziltas B, Bartoloni E, Sebastian A, Romao VC, Solans R, Pasoto SG, Rischmueller M, Galisteo C, Suzuki Y, Trevisani VFM, Fugmann C, Gonzáez A, Carubbi F, Jurcut C, Shimizu T, Retamozo S, Atzeni F, Hofauer B, Melchor S, Gheita T, López JM, Fonseca E, Giacomelli R, Vázquez M, Consani S, Akasbi M, Nakamura H, Szánto A, Farris AD, Wang L, Mandl T, Gattamelata A, Kilic L, Pirkmajer KP, bacar K, Tufan A, de Vita S, Bootsma H, Ramos M, Sjogren Big Data C.

    EClinicalMedicine. 2023. 61. 102062.

    Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV.

    Espineira S, Flores M, Chafino S, Viladés CG, Negredo E, Fernández S, Mallolas J, Villar B, Moreno S, Vidal F, Rull A, Peraire J.

    Front Immunol. 2023. 14p. 1228795-1228795.

    Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program.

    Mestre MT, Recio G, Molina MC, Olona MM.

    Enferm Infecc Microbiol Clin (Engl Ed). 2023. 41. (1):p. 50-51.

    Syndemic conditions and quality of life in the PISCIS Cohort of people living with HIV in Catalonia and the Balearic Islands: a cross sectional study.

    Mesías J, Folch C, Palacio J, Bruguera A, Egea L, Forero CG, Hernández J, Miró JM, Navarro J, Riera M, Peraire J, Alonso L, Díaz Y, Casabona J, Reyes J.

    Health Qual Life Outcomes. 2023. 21. (1):p. 42-42.

    Transient viral rebound in children with perinatally acquired HIV-1 induces a unique soluble immunometabolic signature associated with decreased CD4/CD8 ratio.

    Tarancon L, Peraire J, De Ory SJ, Guirro M, Escosa L, Tato LMP, Antón MP, Piqueras AI, Pérez AV, Gavilán C, Bustillo M, Navarro ML, Viladés CG, Vidal F, Rull A, Muñoz MA.

    116 J Pediatric Infect Dis Soc. 2023. 12. (3):p. 143-151.

    Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.

    Viñuela L, De Salazar A, Fuentes A, Serrano E, Falces I, Pinto A, Portilla I, Masiá M, Peraire J, Gómez JL, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Martínez M, Imaz A, Montero M, Rivero M, Suarez I, Maciá MD, Galán JC, Perez MJ, García LJ, Moreno C, García F.

    J Med Virol. 2023. 95. (12):e29287

    Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

    Ceperuelo-Mallafré V, Reverté L, Peraire J, Madeira A, Maymó-Masip E, López-Dupla M, Gutierrez-Valencia A, Ruiz-Mateos E, Buzón MJ, Jorba R, Vendrell J, Auguet T, Olona M, Vidal F, Rull A, Fernández-Veledo S.
    Front Immunol. 2022;13:912579.
    PMID: 36189213.

    DOI: 10.3389/fimmu.2022.912579

    Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation

    Masip J, Jorba R, López-Dupla M, Domingo P, Pacheco YM, García-Pardo G, Martínez E, Viladés C, Veloso S, Alba V, Olona M, Vidal F, Gómez-Bertomeu F, Peraire J, Rull A.
    Int J Mol Sci. 2022;23(15):8071.
    PMID: 35897644.

    DOI: 10.3390/ijms23158071

    Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

    Masip J, Rallón N, Yeregui E, Olona M, Resino S, Benito JM, Viladés C, García-Pardo G, Alcamí J, Ruiz-Mateos E, Gómez-Bertomeu F, Vargas M, Navarro M, Oteo JA, Pineda JA, Martí A, Alba V, Vidal F, Peraire J, Rull A.
    Front Immunol. 2022;13:822272.
    PMID: 35514981.

    DOI: 10.3389/fimmu.2022.822272

    Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

    Reverté L, Yeregui E, Olona M, Gutiérrez-Valencia A, Buzón MJ, Martí A, Gómez-Bertomeu F, Auguet T, López-Cortés LF, Burgos J, Benavent-Bofill C, Boqué C, García-Pardo G, Ruiz-Mateos E, Mestre MT, Vidal F, Viladés C, Peraire J, Rull A; COVIDOMICS Study Group.
    Clin Transl Med. 2022;12(1):e704.
    PMID: 35075803. PMCID: PMC8787095

    DOI: 10.1002/ctm2.704

    Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia

    Collins DR, Urbach JM, Racenet ZJ, Arshad U, Power KA, Newman RM, Mylvaganam GH, Ly NL, Lian X, Rull A, Rassadkina Y, Yanez AG, Peluso MJ, Deeks SG, Vidal F, Lichterfeld M, Yu XG, Gaiha GD, Allen TM, Walker BD. Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia. Immunity. 2021 Oct 12;54(10):2372-2384.e7. Epub 2021 Sep 7. PMID: 34496223; PMCID: PMC8516715

    DOI: 10.1016/j.immuni.2021.08.007

    Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children

    Tarancón-Diez L, Rull A, Herrero P, Vazquez-Alejo E, Peraire J, Guillén S, Navarro-Gomez ML, Viladés C, Muñoz-Fernández MÁ, Vidal F.
    J Antimicrob Chemother. 2021;76(11):2993-3001.
    PMID: 34463735.

    DOI: 10.1093/jac/dkab277

    Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers

    Malo AI, Peraire J, Ruiz-Mateos E, Masip J, Amigó N, Alcamí J, Moreno S, Girona J, García-Pardo G, Reig R, Vidal F, Castro A, Masana L, Rull A.
    Front Immunol. 2021;12:730691.
    PMID: 34650556. PMCID: PMC8505996

    DOI: 10.3389/fimmu.2021.730691

    Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllers

    Masip J, Gasca-Capote C, Jimenez-Leon MR, Peraire J, Perez-Gomez A, Alba V, Malo AI, Leal L, Martín CR, Rallón N, Viladés C, Olona M, Vidal F, Ruiz-Mateos E, Rull A; ECRIS integrated in the Spanish AIDS Research Network.
    Clin Transl Med. 2021;11(7):e474.
    PMID: 34323411. PMCID: PMC8255061

    DOI: 10.1002/ctm2.474

    Epigenome-wide association study of COVID-19 severity with respiratory failure

    Castro de Moura M, Davalos V, Planas-Serra L, Alvarez-Errico D, Arribas C, Ruiz M, Aguilera-Albesa S, Troya J, Valencia-Ramos J, Vélez-Santamaria V, Rodríguez-Palmero A, Villar-Garcia J, Horcajada JP, Albu S, Casasnovas C, Rull A, Reverte L, Dietl B, Dalmau D, Arranz MJ, Llucià-Carol L, Planas AM, Pérez-Tur J, Fernandez-Cadenas I, Villares P, Tenorio J, Colobran R, Martin-Nalda A, Soler-Palacin P, Vidal F, Pujol A, Esteller M.
    EBioMedicine. 2021;66:103339.
    PMID: 33867313. PMCID: PMC8047083

    DOI: 10.1016/j.ebiom.2021.103339

    High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients

    Yeregui E, Viladés C, Domingo P, Ceausu A, Pacheco YM, Veloso S, Inciarte A, Vidal-González J, Peraire M, Perpiñán C, Falcó V, Masip J, Alba V, Vargas M, Martí A, Reverté L, Mallolas J, Vidal F, Peraire J, Rull A.
    EBioMedicine. 2020;62:103077.
    PMID: 33166788. PMCID: PMC7653063

    DOI: 10.1016/j.ebiom.2020.103077

    Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects

    Rosado-Sánchez I, De Pablo-Bernal R, Rull A, Gónzalez J, Moreno S, Vinuesa D, Estrada V, Muñoz-Fernández MÁ, Vidal F, Leal M, Pacheco YM.
    Front Immunol. 2020;11:581307.
    PMID: 33240269. PMCID: PMC7677300

    DOI: 10.3389/fimmu.2020.581307

    Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)

    Solans-Laqué R, Rodriguez-Carballeira M, Rios-Blanco JJ, Fraile G, Sáez-Comet L, Martinez-Zapico A, Frutos B, Solanich X, Fonseca-Aizpuru E, Pasquau-Liaño F, Zamora M, Oristrell J, Fanlo P, Lopez-Dupla M, Abdilla M, García-Sánchez I, Sopeña B, Castillo MJ, Perales I, Callejas JL.
    Arthritis Care Res (Hoboken). 2020;72(7):1001-1010.
    PMID: 31033198.

    DOI: 10.1002/acr.23912

    The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

    Guerrero-Beltrán C, Martínez-Sanz J, Álvarez M, Olalla J, García-Álvarez M, Iribarren JA, Masiá M, Montero M, García-Bujalance S, Blanco JR, Rivero M, García-Fraile LJ, Espinosa N, Rodríguez C, Aguilera A, Vidal-Ampurdanes MC, Martínez M, Iborra A, Imaz A, Gómez-Sirvent JL, Peraire J, Portilla J, Caballero E, Alejos B, García F, Moreno S; CoRIS.
    J Antimicrob Chemother. 2020;75(5):1294-1300.
    PMID: 32030406.

    DOI: 10.1093/jac/dkaa009

    Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial

    Curran A, Rull A, Navarro J, Vidal-González J, Martin-Castillo M, Burgos J, Falcó V, Ribera E, Torrella A, Planas B, Peraire J, Crespo M.
    J Clin Med. 2020;9(5):1246.
    PMID: 32344934. PMCID: PMC7288166

    DOI: 10.3390/jcm9051246

    New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144

    Hernández-Walias F, Ruiz-de-León MJ, Rosado-Sánchez I, Vázquez E, Leal M, Moreno S, Vidal F, Blanco J, Pacheco YM, Vallejo A.
    Sci Rep. 2020;10(1):2937.
    PMID: 32076107.

    DOI: 10.1038/s41598-020-60073-8

    CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients

    Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F.
    Cell MolImmunol. 2019;16(12):940-942.
    PMID: 31467415.

    DOI: 10.1038/s41423-019-0275-4

    IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status

    Ceausu A, Rodríguez-Gallego E, Peraire J, López-Dupla M, Domingo P, Viladés C, Vidal-Gonzalez J, Peraire M, Perpiñán C, Pacheco YM, Veloso S, Alba V, Vargas M, Castellano AJ, Ruiz-Mateos E, Mallolas J, Vidal F, Rull A.
    Sci Rep. 2019;9(1):15722.

    PMID: 31673011. PMCID: PMC6823538

    DOI: 10.1038/s41598-019-52025-8

    Drug-drug interactions when treating HIV-related metabolic disorders

    Gutierrez MDM, Mateo MG, Corbacho N, Vidal F, Domingo P.
    Expert Opin Drug Metab Toxicol. 2019;15(10):787-802.
    PMID: 31512529.

    DOI: 10.1080/17425255.2019.1667334

    Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

    Teira R, Espinosa N, Gutiérrez MM, Montero M, Martínez E, González F, Lozano de León F, Téllez F, Galindo MJ, Peraire J, Deig E, Muñoz-Sánchez P; para el Grupo de estudio VACH.
    Enferm Infecc Microbiol Clin. 2019;37(6):361-366.
    PMID: 30514587.

    DOI: 10.1016/j.eimc.2018.09.008

    Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

    Alvarez M, Casas P, de Salazar A, Chueca N, Guerrero-Beltran C, Rodríguez C,Imaz A, Espinosa N, García-Bujalance S, Pérez-Elías MJ, García-Alvarez M, Iribarren JA, Santos J, Dalmau D, Aguilera A, Vinuesa D, Gutiérrez F, Piérola B, Molina JM, Peraire J, Portilla I, Gómez-Sirvent JL, Olalla J, Galera C, Blanco JR, Riera M, García-Fraile L, Navarro G, Curran A, Poveda E, García F; CoRIS.
    J Antimicrob Chemother. 2019;74(6):1693-1700.
    PMID: 30838386.

    DOI: 10.1093/jac/dkz067

    Does choice of antiretroviral drugs matter for inflammation?

    Gutierrez MDM, Mateo MG, Vidal F, Domingo P.
    Expert Rev Clin Pharmacol. 2019;12(5):389-396.
    PMID: 31017494.

    DOI: 10.1080/17512433.2019.1605902

    Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients

    Rosado-Sánchez I, Rodríguez-Gallego E, Peraire J, Viladés C, Herrero P, Fanjul F, Gutiérrez F, Bernal E, Pelazas R, Leal M, Veloso S, López-Dupla M, Blanco J, Vidal F, Pacheco YM, Rull A.
    Clin Sci (Lond). 2019;133(8):997-1010.
    PMID: 30952809.

    DOI: 10.1042/CS20190111

    Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers A study of the Spanish CoRIS cohort,2004-2015

    Masiá M, Padilla S, García JA, García-Abellán J, Fernández M, Bernardino I, Montero M, Peraire J, Pernas B, Gutiérrez F.
    PLoS One. 2019;14(4):e0215507.
    PMID: 31026289.

    DOI: 10.1371/journal.pone.0215507

    Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection

    Tarancon-Diez L, Rodríguez-Gallego E, Rull A, Peraire J, Viladés C, Portilla I, Jimenez-Leon MR, Alba V, Herrero P, Leal M, Ruiz-Mateos E, Vidal F; ECRIS integrated in the Spanish AIDS Research Network.
    EBioMedicine. 2019;42:86-96.
    PMID: 30879922. PMCID: PMC6491381

    DOI: 10.1016/j.ebiom.2019.03.004

    Discontinuation of dolutegravir, elvitegravir / cobicistat and raltegravir because of toxicity in a prospective cohort

    Llibre JM, Montoliu A, Miró JM, Domingo P, Riera M, Tiraboschi J, Curran A, Homar F, Ambrosioni J, Abdulghani N, Force L, Peraire J, Casabona J; PISCIS Cohort group.
    HIV Med. 2019;20(3):237-247.
    PMID: 30688007.

    DOI: 10.1111/hiv.12710

    Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control

    Rodríguez-Gallego E, Tarancón-Diez L, García F, Del Romero J, Benito JM, Alba V, Herrero P, Rull A, Dominguez-Molina B, Martinez-Madrid O, Martin-Pena L, Pulido F, León A, Rodríguez C, Rallón N, Peraire J, Viladés C, Leal M, Vidal F, Ruiz-Mateos E; HIV-1 Elite Controllers Study Group (ECRIS), Spanish AIDS ResearchNetwork.
    J Infect Dis. 2019;219(6):867-876.
    PMID: 30312441.

    DOI: 10.1093/infdis/jiy599

    Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015

    Jarrin I, Suarez-Garcia I, Moreno C, Tasias M, Del Romero J, Palacios R, Peraire J, Gorgolas M, Moreno S; Cohort of the Spanish HIV/AIDS Research Network (CoRIS).
    AntivirTher. 2019;24(3):167-175.
    PMID: 30747107.

    DOI: 10.3851/IMP3297

    Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023).

    Muñoz Báez P, Illescas López M, de Salazar A, Falces Romero I, Pinto A, Portilla I, Masiá M, Peraire J, Alemán Valls MR, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Gisbert L, Imaz A, Montero M, Navarro Marcotegui M, Suárez-García I, Riera M, Pérez Elias MJ, Galán JC, García Fraile LJ, Sanz J, Ibarra Ugarte S, Bernal E, Blanco JR, Navarro G, Martínez O, Viciana Ramos MI, Mohamen-Balghata MO, Delgado E, Thompson MM, Moreno C, CoRIS C, Fuentes A, García F. 01/06/2026. Open forum infectious diseases. 13. PMID: 42266788. doi: 10.1093/ofid/ofag296

    Development and optimization of an easy to interpret loop-mediated isothermal amplification (LAMP) assay for the identification of bacterial pathogens causing childhood pneumonia.

    Martínez-Trejo A, Vergara A, Gatti G, Guiral E, Otero J, Sánchez A, Rull A, Calavia O, Papaleo A, Farré R, Vila J. 02/03/2026. Frontiers in Microbiology. 17. PMID: 41847200. doi: 10.3389/fmicb.2026.1748456

    Subphenotype- and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials.

    Escrihuela-Vidal F, Larrauri JG, López-Contreras J, Euba G, Vázquez A, Gómez-Zorrilla S, López-Cortés LE, Gasch O, Aparicio-Minguijón E, Escudero-Sánchez R, Pérez-Rodríguez MT, Rodríguez-Pardo D, Jover-Sáenz A, García-Pardo G, Rodríguez-Baño J, Pujol M, Carratalà J, Gutiérrez-Gutiérrez B. 01/03/2026. Lancet Regional Health-Europe. 62. PMID: 41788427. doi: 10.1016/j.lanepe.2026.101611

    Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIV.

    Martinez-Velasco M, Sánchez-Herrero JF, Ibañez L, Velli P, Muñoz-Lopez FM, Cairó M, Jaen A, Font R, Martinez-Lacasa X, Royo J, Peraire J, Faro-Míguez N, Rivero A, Olalla J, Ruiz-Seco P, López-Cortés LF, Sumoy L, Massanella M, Dalmau D. 12/02/2026. Medical Sciences (basel, Switzerland). 14. PMID: 41718132. doi: 10.3390/medsci14010085

    Ventilator-Associated Pneumonia (VAP) in Neurocritical Patients: The Hidden Dialog of Brain and Infection

    Rodríguez, A, Claverias, L, Martín-Loeches, I, Bertomeu, FG, Plana, EP, Rosich, S, Blázquez, V, Torrez, DHC, Lau, R, Bodí, M. 17/12/2025. Biomedicines. 13. PMID: 41463120. doi: 10.3390/biomedicines13123112

    Profile of suicides in a spanish cohort of people living with HIV (PLWH)

    Olalla, J, Peraire, J, Fernández, RCG, Faro, N, Castillo-Navarro, AM, Galindo, P, Espinosa, N, Pérez-Stachowski, J, Del Arco, A, de la Torre, J, Rivas, F. 01/12/2025. Journal of Affective Disorders Reports. 22. doi: 10.1016/j.jadr.2025.100980

    Profile of suicides in a spanish cohort of people living with HIV (PLWH) (vol 22, 100980, 2025)

    Olalla, J, Peraire, J, Fernández, RCG, Faro, N, Castillo-Navarro, AM, Galindo, P, Espinosa, N, Pérez-Stachowski, J, del Arco, A, de la Torre, J, Rivas, F. 01/12/2025. Journal of Affective Disorders Reports. 22. doi: 10.1016/j.jadr.2025.100987

    Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV

    Chafino, S, Tarancon-Diez, L, Hurtado-Gallego, J, Flores-Piñas, M, Alcolea, S, Olveira, A, Navarro, ML, Fernández-Arroyo, S, Viladés, C, Montes, ML, Vidal, F, Peraire, J, Rull, A, Sainz, T. 23/10/2025. Communications Medicine. 5. PMID: 41131087. doi: 10.1038/s43856-025-01149-2

    Detection of Campylobacter spp. and Yersina spp. in chicken burgers: Critical evaluation of CIN medium and characterization of psychrotolerant microbiota in commercial samples from Reus (Tarragona, Spain)

    Sanchis, M, Camuña-Pardo, L, Quijada, LM, Escobar, AP, Gomez-Bertomeu, F, Glikman, AMS. 01/10/2025. Revista Argentina De Microbiologia. 57. PMID: 40701875. doi: 10.1016/j.ram.2025.06.002

    Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery

    Garrido-Rodriguez, V, Bulnes-Ramos, A, Olivas-Martinez, I, Pozo-Balado, MD, Tejerina-Picado, F, Gutierrez, F, Marco-Sánchez, C, Tiraboschi, JM, Castillo-Navarro, A, Bernal, E, Garcia-Guerrero, MC, Puertas, MC, Peraire, J, Rull, A, Martinez-Picado, J, Pacheco, YM, CoRIS Cohort. 08/09/2025. Frontiers in immunology. 16. PMID: 40990014. doi: 10.3389/fimmu.2025.1617674

    Appropriateness of urine culture requests in primary care in Spain: A cross-sectional descriptive study

    Fernández-García, S, Monfà, R, Jiménez, CM, Giner-Soriano, M, Gómez, F, Moragas, A. 01/07/2025. Atencion Primaria. 57. PMID: 39799637. doi: 10.1016/j.aprim.2024.103208

    Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.

    Ryan P, Blanco JL, Masia M, Garcia-Fraile L, Crusells MJ, Domingo P, Curran A, Guerri-Fernandez R, Bernal E, Bravo J, Revollo B, Macias J, Tiraboschi JM, Montejano R, Amador C, Torralba M, Merino D, Diaz-Brito V, Galindo MJ, Ferra S, Villoslada A, Losa JE, Fanjul FJ, Perez-Stachowski X, Peraire J, Portilla J, de la Fuente S, Dueñas C, Vazquez MJ, Di Gregorio S, Esteban H, Gil P, de Miguel M, Alejos B, Martínez E. 01/07/2025. LANCET HIV. 12. PMID: 40489982. doi: 10.1016/S2352-3018(25)00105-5

    Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review

    Pais, MM, Zaragoza, R, Martín-Loeches, I, Gómez-Bertomeu, FF, Rodríguez, A. 06/05/2025. Journal Of Fungi. 11. PMID: 40422696. doi: 10.3390/jof11050362

    Correction: Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study.

    Vazquez-Alejo E, De La Sierra Espinar-Buitrago M, Magro-Lopez E, Tarancon-Diez L, Díez C, Bernardino JI, Rull A, De Los Santos I, Alonso R, Zamora A, Jiménez JL, Muñoz-Fernández MÁ. 06/05/2025. MEDICAL MICROBIOLOGY AND IMMUNOLOGY. 214. PMID: 40327102. doi: 10.1007/s00430-025-00829-z

    Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time.

    Izquierdo R, Suárez-García I, Marco-Sánchez C, Pérez-Latorre L, Riera M, Cano J, Viladés C, Reus S, Olalla J, González-Ruano P, Orviz E, Díaz A, Moreno S, Jarrín I. 01/04/2025. Hiv Medicine. 26. PMID: 39835516. doi: 10.1111/hiv.13762

    Omics for searching plasma biomarkers associated with unfavorable COVID-19 progression in hypertensive patients

    Sánchez, A, García-Pardo, G, Martí, A, Gómez-Bertomeu, F, Chafino, S, Massanella, M, Flores-Piñas, M, Cedó, L, Vidal, F, Peraire, J, Rull, A. 25/03/2025. Scientific Reports. 15. PMID: 40133696. doi: 10.1038/s41598-025-94725-4

    Oral antibiotic prophylaxis induces changes in the microbiology of surgical site infection after colorectal surgery. A matched comparative study.

    Flores-Yelamos M, Juvany M, Badia JM, Vázquez A, Pascual M, Parés D, Almendral A, Limón E, Pujol M, Gomila-Grange A. 01/02/2025. Colorectal Disease. 27. PMID: 39887585. doi: 10.1111/codi.70008

    Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands.

    Bruguera A, Nomah DK, Moreno-Fornés S, Martinez E, Negredo E, Tiraboschi J, Navarro J, Domingo P, Fanjul F, Villoslada A, Peraire J, Jaen A, Miró JM, Casabona J, Reyes-Urueña J. 01/01/2025. Aids. 39. PMID: 39639721. doi: 10.1097/QAD.0000000000004018

    Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV.

    Casares-Jimenez M, Rivero-Juarez A, Lopez-Lopez P, Montes ML, Navarro-Soler R, Peraire J, Espinosa N, Alemán-Valls MR, Garcia-Garcia T, Caballero-Gomez J, Corona-Mata D, Perez-Valero I, Ulrich RG, Rivero A. 01/12/2024. Emerging Microbes & Infections. 13. PMID: 38095070. doi: 10.1080/22221751.2023.2295389

    Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis

    Nomah, DK, Díaz, Y, Bruguera, A, Moreno-Fornés, S, Aceiton, J, Reyes-Urueña, J, Llibre, JM, Falcó, V, Imaz, A, Fanjul, FJ, Peraire, J, Deig, E, Domingo, P, Inciarte, A, Casabona, J, Miró, JM. 02/01/2024. Open forum infectious diseases. 11. PMID: 38221982. doi: 10.1093/ofid/ofad693

    Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study.

    Vazquez-Alejo E, De La Sierra Espinar-Buitrago M, Magro-Lopez E, Tarancon-Diez L, Díez C, Bernardino JI, Rull A, De Los Santos I, Alonso R, Zamora A, Jiménez JL, Muñoz-Fernández MÁ. 26/12/2024. MEDICAL MICROBIOLOGY AND IMMUNOLOGY. 214. PMID: 39724280. doi: 10.1007/s00430-024-00813-z

    The persistence of low CD4/CD8 ratio chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function

    Garrido-Rodríguez, V, Bulnes-Ramos, A, Olivas-Martínez, I, Pozo-Balado, MD, Alvarez-Ríos, AI, Gutiérrez, F, Izquierdo, R, García, F, Tiraboschi, JM, Vera-Méndez, F, Peraire, J, Rull, A, Pacheco, YM, CoRIS Cohort. 01/12/2024. Journal Of Microbiology Immunology And Infection. 57. PMID: 39209566. doi: 10.1016/j.jmii.2024.08.007

    Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients (vol 17, e0269875, 2022)

    Trujillo-Rodriguez, M, Muñoz-Muela, E, Serna-Gallego, A, Praena-Fernández, JM, Pérez-Gómez, A, Gasca-Capote, C, Vitallé, J, Peraire, J, Palacios-Baena, ZR, Cabrera, JJ, Ruiz-Mateos, E, Poveda, E, López-Cortés, LE, Rull, A, Gutierrez-Valencia, A, López-Cortés, LF. 21/11/2024. Plos One. 19. PMID: 39570969. doi: 10.1371/journal.pone.0314574

    Duration of severe and moderate symptoms in pharyngitis by cause

    Moragas, A, Sarvisé, C, Gómez, F, Picó-Plana, E, Crispi, S, Llor, C. 01/11/2024. Atencion Primaria. 56. PMID: 38875835. doi: 10.1016/j.aprim.2024.102994

    Profile of suicide cases in the Spanish CoRIS cohort between 2004-2022

    Olalla, J, Del Arco, A, Riera, M, Peraire, J, Bernal, E, De la Torre, J, Castillo-Navarro, A, Martínez-Fernández, L, Pérez-Stachowski, J, Moreno, S. 01/11/2024. Journal Of The International Aids Society. 27

    Changes in patient-reported neuropsychological outcomes in virologically suppressed persons with HIV switching to DTG/3TC or BIC/FTC/TAF: a substudy of the PASO-DOBLE randomized clinical trial

    Garcia-Fraile, L, Masia, M, Crusells-Canales, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Sanchez, RM, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Puerto, MJG, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, Moral, SD, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Blanco-Arevalo, JL, Ryan, P, Alejos, B, Martinez, E. 01/11/2024. Journal Of The International Aids Society. 27

    Prevalence trends of active HCV infection among people with HIV in Spain (2002-2023): nearing elimination

    Berenguer, J, Arcos, MM, Fanciulli, C, Vivancos, MJ, Domingo, P, Hernando, A, Sánz-Pérez, MN, Ryan, P, Navarro, J, Palacios, R, Morano, LE, Iribarren, JA, Martínez, R, Puerto, MJG, Santos, I, López-Cruz, I, Roman, AR, Giner, L, Fariñas, C, García, C, Montero, M, Ferrero, OL, Villoslada, A, Soler-González, JF, Sanz, J, Rodríguez, S, Losa, JE, Bernal, E, Veloso, S, Pérez-Martínez, L, Mateos, F, Arbonés, L, Franch, R, Corps, D, Martín, C, Alonso, G, Olmos, MC, Silvariño, R, Teira, R, Belinchon, O, De Miguel, M, Jarrín, I, González-García, J. 01/11/2024. Journal Of The International Aids Society. 27

    Telomere length and 4-year changes in cognitive function in an older Mediterranean population at high risk of cardiovascular disease

    de la Puente, MF, Marti, A, Canudas, S, Zalba, G, Razquin, C, Boccardi, V, Mecocci, P, Babio, N, Castañer-Niño, O, Toledo, E, Buil-Cosiales, P, Salas-Salvadó, J, García-Calzón, S. 10/10/2024. Age And Ageing. 53. PMID: 39385582. doi: 10.1093/ageing/afae216

    A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective

    Rodríguez, A, Gómez, J, Martín-Loeches, I, Claverias, L, Díaz, E, Zaragoza, R, Borges-Sa, M, Gómez-Bertomeu, F, Franquet, A, Trefler, S, Garzón, CG, Cortés, L, Alés, F, Sancho, S, Solé-Violán, J, Estella, A, Berrueta, J, García-Martínez, A, Suberviola, B, Guardiola, JJ, Bodí, M. 01/10/2024. Antibiotics-Basel. 13. PMID: 39452234. doi: 10.3390/antibiotics13100968

    Bilateral retinal vasculopathy in a patient with aplastic anemia due to dyskeratosis congenita

    Castro-Díaz, M, Solé-Forteza, E, Montoya-Ortega, S, López-Dupla, JM. 01/10/2024. Journal Francais D Ophtalmologie. 47. PMID: 39068096. doi: 10.1016/j.jfo.2024.104249

    Temporal relationship between sarcoidosis and malignancies in a nationwide cohort of 1942 patients

    Brito-Zerón, P, Flores-Chávez, A, González-de-Paz, L, Feijoo-Massó, C, de Escalante, B, González-García, A, Gómez-de-la-Torre, R, Policarpo-Torres, G, Alguacil, A, García-Morillo, JS, López-Dupla, M, Robles, A, Bonet, M, Gómez-Lozano, A, Toledo, N, Chamorro, A, Morcillo, C, Cruz-Caparrós, G, de Miguel-Campo, B, Akasbi, M, Fonseca-Aizpuru, E, Gómez-Cerezo, JF, Mas-Maresma, L, Vallejo-Grijalba, J, Starita-Fajardo, G, Sánchez-Niño, R, Ramos-Casals, M. 08/07/2024. Postgraduate Medical Journal. 100. PMID: 38972066. doi: 10.1093/postmj/qgae045

    Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    Moreno, C, Izquierdo, R, Alejos, B, Hernando, V, de la Cámara, SP, Peraire, J, Macías, J, Bernal, E, Albendín-Iglesias, H, Alcaraz, B, Suárez-Gárcia, I, Moreno, S, Jarrín, I. 01/07/2024. AIDS PATIENT CARE AND STDS. 38. PMID: 38916077. doi: 10.1089/apc.2024.0093

    Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial

    Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Alejos, B, Martinez, E. 01/07/2024. Journal Of The International Aids Society. 27

    Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

    de Lazzari, E, Negredo, EB, Domingo, P, Tiraboschi, JM, Ribera, E, Abdulghani, N, Alba, V, Fernández-Arroyo, S, Viladés, C, Peraire, J, Gatell, JM, Blanco, JL, Vidal, F, Rull, A, Martinez, E. 02/05/2024. Journal Of Antimicrobial Chemotherapy. 79. PMID: 38546974. doi: 10.1093/jac/dkae083

    Major cardiovascular events after COVID-19 in people with HIV.

    Martín-Iguacel R, Moreno-Fornés S, Bruguera A, Aceitón J, Nomah DK, González-Cordón A, Domingo P, Curran A, Imaz A, Juanola DD, Peraire J, Borjabad B, Fernandez LA, Johansen IS, Miró JM, Casabona J, Llibre JM. 01/05/2024. Clinical Microbiology And Infection. 30. PMID: 38342439. doi: 10.1016/j.cmi.2024.02.006

    The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Gasca-Capote, C, Lian, XD, Gao, C, Roseto, IC, Jiménez-Léon, MR, Gladkov, G, Camacho-Sojo, MI, Perez-Gomez, A, Gallego, I, Lopez-Cortes, LE, Bachiller, S, Vitalle, J, Benhnia, MRE, Ostos, FJ, Collado-Romacho, AR, Santos, J, Palacios, R, Gomez-Ayerbe, C, Munoz-Medina, L, Ruiz-Sancho, A, Frias, M, Rivero-Juarez, A, Roca-Oporto, C, Hidalgo-Tenorio, C, Rull, A, Olalla, J, Lopez-Ruz, MA, Vidal, F, Vilades, C, Mastrangelo, A, Cavassini, M, Espinosa, N, Perreau, M, Peraire, J, Rivero, A, López-Cortes, LF, Lichterfeld, M, Yu, XG, Ruiz-Mateos, E. 15/04/2024. Journal Of Clinical Investigation. 134. PMID: 38376918. doi: 10.1172/JCI174215

    Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase

    Peraire, J, García-Pardo, G, Chafino, S, Sánchez, A, Botero-Gallego, M, Olona, M, Espineira, S, Reverté, L, Skouridou, V, Peiró, OM, Gómez-Bertomeu, F, Vidal, F, O’ Sullivan, CK, Rull, A. 06/04/2024. European Journal Of Medical Research. 29. PMID: 38581072. doi: 10.1186/s40001-024-01824-5

    Response to Letter to the Editor Clinical Nutrition

    Marti, A, de la Puente, MF, Canudas, S, García-Calzón, S, Salas-Salvadó, J. 01/04/2024. Clinical Nutrition. 43. PMID: 38438287. doi: 10.1016/j.clnu.2024.02.025

    Prevalence and prognostic implications of myocardial injury across different waves of COVID-19

    Peiró, OM, Delgado-Cornejo, JR, Sánchez-Giménez, R, del-Moral-Ronda, V, Lal-Trehan, N, Rocamora-Horrach, M, Carrasquer, A, Peraire, J, Fort-Gallifa, I, Bardaji, A. 22/02/2024. Frontiers In Cardiovascular Medicine. 11. PMID: 38455719. doi: 10.3389/fcvm.2024.1297824

    Clinical and Microbiological Impact of Implementing a Decision Support Algorithm through Microbiologic Rapid Diagnosis in Critically Ill Patients: An Epidemiological Retrospective Pre-/Post-Intervention Study.

    Rodríguez A, Gómez F, Sarvisé C, Gutiérrez C, Giralt MG, Guerrero-Torres MD, Pardo-Granell S, Picó-Plana E, Benavent-Bofill C, Trefler S, Berrueta J, Canadell L, Claverias L, Esteve Pitarch E, Olona M, García Pardo G, Teixidó X, Bordonado L, Sans MT, Bodí M. 16/12/2023. Biomedicines. 11. PMID: 38137551. doi: 10.3390/biomedicines11123330

    Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project.

    Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, Fernández-Galán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, Madinaveitia-Ochoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ, Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E, Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, Arévalo-Vargas I, Andrade-Campos M, Giraldo P. 15/12/2023. Orphanet Journal Of Rare Diseases. 18. PMID: 38102667. doi: 10.1186/s13023-023-02939-4

    Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.

    Viñuela L, de Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, Portilla I, Masiá M, Peraire J, Gómez-Sirvent JL, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Martínez-Velasco M, Imaz A, Montero M, Rivero M, Suarez-García I, Maciá MD, Galán JC, Perez-Elias MJ, García-Fraile LJ, Moreno C, Garcia F. 01/12/2023. Journal Of Medical Virology. 95. PMID: 38084763. doi: 10.1002/jmv.29287

    Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery

    Sánchez, A, García-Pardo, G, Gómez-Bertomeu, F, López-Dupla, M, Foguet-Romero, E, Buzón, MJ, Almirante, B, Olona, M, Fernández-Veledo, S, Vidal, F, Chafino, S, Rull, A, COVIDOMICS Study Grp. 20/10/2023. iScience. 26. PMID: 37810253. doi: 10.1016/j.isci.2023.107948

    Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV

    Espineira, S, Flores-Piñas, M, Chafino, S, Viladés, C, Negredo, E, Fernández-Arroyo, S, Mallolas, J, Villar, B, Moreno, S, Vidal, F, Rull, A, Peraire, J. 15/08/2023. Frontiers in immunology. 14. PMID: 37649488. doi: 10.3389/fimmu.2023.1228795

    A metagenome-wide association study of HIV disease progression in HIV controllers

    Real, LM, Sáez, ME, Corma-Gómez, A, Gonzalez-Pérez, A, Thorball, C, Ruiz, R, Jimenez-Leon, MR, Gonzalez-Serna, A, Gasca-Capote, C, Bravo, MJ, Royo, JL, Perez-Gomez, A, Camacho-Sojo, MI, Gallego, I, Vitalle, J, Bachiller, S, Gutierrez-Valencia, A, Vidal, F, Fellay, J, Lichterfeld, M, Ruiz-Mateos, E. 21/07/2023. iScience. 26. PMID: 37456859. doi: 10.1016/j.isci.2023.107214

    Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study

    Ingle, SM, Miro, JM, May, MT, Cain, LE, Schwimmer, C, Zangerle, R, Sambatakou, H, Cazanave, C, Reiss, P, Brandes, V, Bucher, HC, Sabin, C, Vidal, F, Obel, N, Mocroft, A, Wittkop, L, Monforte, AD, Torti, C, Mussini, C, Furrer, H, Konopnicki, D, Teira, R, Saag, MS, Crane, HM, Moore, RD, Jacobson, JM, Mathews, WC, Geng, EL, Eron, JJ, Althoff, KN, Kroch, A, Lang, RY, Gill, MJ, Sterne, JAC. 05/07/2023. Clinical Infectious Diseases. 77. PMID: 36883578. doi: 10.1093/cid/ciad122

    Fucosylated N-glycans as early biomarkers of COVID-19 severity

    Paton, B, Herrero, P, Peraire, J, del Pino, A, Chafino, S, Martinez-Picado, J, Gómez-Bertomeu, F, Rull, A, Canela, N, Suárez, M. 05/06/2023. Frontiers in immunology. 14. PMID: 37342334. doi: 10.3389/fimmu.2023.1204661

    Syndemic conditions and quality of life in the PISCIS Cohort of people living with HIV in Catalonia and the Balearic Islands: a cross sectional study (vol 21, 42, 2023)

    Mesías-Gazmuri, J, Folch, C, Palacio-Vieira, J, Bruguera, A, Egea-Cortés, L, Forero, CG, Hernández, J, Miró, JM, Navarro, J, Riera, M, Peraire, J, Alonso-García, L, Díaz, Y, Casabona, J, Reyes-Urueña, J. 30/05/2023. Health And Quality Of Life Outcomes. 21. PMID: 37254155. doi: 10.1186/s12955-023-02139-5

    Syndemic conditions and quality of life in the PISCIS Cohort of people living with HIV in Catalonia and the Balearic Islands: a cross sectional study

    Mesías-Gazmuri, J, Folch, C, Palacio-Vieira, J, Bruguera, A, Egea-Cortés, L, Forero, CG, Hernández, J, Miró, JM, Navarro, J, Riera, M, Peraire, J, Alonso-García, L, Díaz, Y, Casabona, J, Reyes-Urueña, J. 10/05/2023. Health And Quality Of Life Outcomes. 21. PMID: 37165368. doi: 10.1186/s12955-023-02120-2

    Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study.

    Reyes LF, Rodriguez A, Fuentes YV, Duque S, García-Gallo E, Bastidas A, Serrano-Mayorga CC, Ibáñez-Prada ED, Moreno G, Ramirez-Valbuena PC, Ospina-Tascon G, Hernandez G, Silva E, Díaz AM, Jibaja M, Vera-Alarcon M, Díaz E, Bodí M, Solé-Violán J, Ferrer R, Albaya-Moreno A, Socias L, Figueroa W, Lozano-Villanueva JL, Varón-Vega F, Estella Á, Loza-Vazquez A, Jorge-García R, Sancho I, Shankar-Hari M, Martin-Loeches I. 21/04/2023. Scientific Reports. 13. PMID: 37085552. doi: 10.1038/s41598-023-32265-5

    Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio

    Tarancon-Diez, L, Peraire, J, de Ory, SJ, Guirro, M, Escosa, L, Tato, LMP, Antón, MP, Piqueras, AI, Pérez, AV, Gavilán, C, Bustillo-Alonso, M, Navarro, ML, Viladés, C, Vidal, F, Rull, A, Muñoz-Fernández, MA. 18/04/2023. Journal of the Pediatric Infectious Diseases Society. 12. PMID: 36727571. doi: 10.1093/jpids/piad008

    Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

    Burgos, J, Moreno-Fornés, S, Reyes-Urueña, J, Bruguera, A, Martín-Iguacel, R, Raventos, B, Llibre, JM, Imaz, A, Peraire, J, Orti, AJ, Dalmau, D, Casabona, J, Miró, JM, Falcó, V. 01/01/2023. Journal Of Antimicrobial Chemotherapy. 78. PMID: 36308326. doi: 10.1093/jac/dkac361

    Reinfection confirmed by SARS-CoV-2 in a healthcare professional detected by an in-hospital infection control program

    Mestre-Prad MT, Recio-Comí G, Molina-Clavero MC, Olona-Cabases MM. 01/01/2023. Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 41. PMID: 36456432. doi: 10.1016/j.eimce.2022.11.004

    Reinfección confirmada por SARS-CoV-2 en profesional sanitario detectada mediante un programa de control de la infección intrahospitalaria.

    Mestre-Prad MT, Recio-Comí G, Molina-Clavero MC, Olona-Cabases MM. 01/01/2023. Enfermedades Infecciosas Y Microbiologia Clinica. 41. PMID: 35469336. doi: 10.1016/j.eimc.2022.02.013

    Molecular and serological survey of rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV in Spain

    Rivero-Juarez, A, Casares-Jimenez, M, Lopez-Lopez, P, Montes, ML, Navarro-Soler, R, Peraire, J, Espinosa, N, Alemán-Valls, MR, Garcia-Garcia, T, Caballero-Gomez, J, Corona-Mata, D, Perez-Valero, I, Ulrich, RG, Rivero, A. 01/12/2023. Hiv Medicine. 24

    Suicide mortality trends and predictors in the PISICS cohort of people living with HIV in Catalonia and the Balearic Islands, Spain

    Nomah, DK, Moreno-Fornés, S, Díaz, Y, Bruguera, A, Burgos, J, Knobel, H, Domingo, P, Peñaranda, M, Arbonés, L, Revollo, B, Peraire, J, Leon, E, Tiraboschi, J, Foncillas, A, Miro, JM, Casabona, J. 01/12/2023. Hiv Medicine. 24

    Risk of major cardiovascular events after COVID-19 in people with HIV: The prospective PISCIS cohort study

    Martin-Iguacel, R, Moreno, S, Bruguera, A, Aceitón, J, González-Cordón, A, Domingo, P, Curran, A, Imaz, A, Juanola, DD, Peraire, J, Borjabad, B, Fernandez, LA, Johansen, IS, Miro, JM, Casabona, J, Llibre, JM. 01/12/2023. Hiv Medicine. 24

    The lockdown of the locked-in: experiences of persons with Locked-in Syndrome during COVID-19 pandemic

    Masana, L, Vidal, F. 03/11/2023. DISABILITY & SOCIETY. 40. doi: 10.1080/09687599.2023.2279484

    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Grillo, S, Pujol, M, Miró, JM, López-Contreras, J, Euba, G, Gasch, O, Boix-Palop, L, Garcia-País, MJ, Pérez-Rodríguez, MT, Gomez-Zorrilla, S, Oriol, I, López-Cortés, LE, Pedro-Botet, ML, San-Juan, R, Aguado, JM, Gioia, F, Iftimie, S, Morata, L, Jover-Sáenz, A, García-Pardo, G, Loeches, B, Izquierdo-Cárdenas, A, Goikoetxea, AJ, Gomila-Grange, A, Dietl, B, Berbel, D, Videla, S, Hereu, P, Padulles, A, Pallarès, N, Tebé, C, Cuervo, G, Carratalà, J, SAFO Study Grp. 01/10/2023. Nature Medicine. 29. PMID: 37783969. doi: 10.1038/s41591-023-02569-0

    Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study

    Brito-Zerón, P, Flores-Chávez, A, Horváth, IF, Rasmussen, A, Li, XM, Olsson, P, Vissink, A, Priori, R, Armagan, B, Hernandez-Molina, G, Praprotnik, S, Quartuccio, L, Inanç, N, Özkiziltas, B, Bartoloni, E, Sebastian, A, Romao, VC, Solans, R, Pasoto, SG, Rischmueller, M, Galisteo, C, Suzuki, Y, Trevisani, VFM, Fugmann, C, Gonzáez-García, A, Carubbi, F, Jurcut, C, Shimizu, T, Retamozo, S, Atzeni, F, Hofauer, B, Melchor-Díaz, S, Gheita, T, López-Dupla, M, Fonseca-Aizpuru, E, Giacomelli, R, Vázquez, M, Consani, S, Akasbi, M, Nakamura, H, Szánto, A, Farris, AD, Wang, L, Mandl, T, Gattamelata, A, Kilic, L, Pirkmajer, KP, Abacar, K, Tufan, A, de Vita, S, Bootsma, H, Ramos-Casals, M. 01/07/2023. EClinicalMedicine. 61. PMID: 37457113. doi: 10.1016/j.eclinm.2023.102062

    Effectiveness of a direct care action strategy at the drug addiction center (test and treat in point of care) for the detection and treatment of hepatitis C in drug users on opioid agonist substitution therapy

    Rodríguez, A, de Miera, IS, Sendra, MA, Méndez, P, Roch, MA, Vargas, M, Montoliu, S, Pardo, A, Colom, J, Boniquet, JCQ. 01/06/2023. Journal Of Hepatology. 78

    Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    Suárez-García, I, Alejos, B, Hernando, V, Viñuela, L, García, MV, Rial-Crestelo, D, Elías, MJP, Iglesias, HA, Peraire, J, Tiraboschi, J, Díaz, A, Moreno, S, Jarrin, I. 01/06/2023. Journal Of Antimicrobial Chemotherapy. 78. PMID: 37099559. doi: 10.1093/jac/dkad102

    Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn's disease

    Qanneta, R, Feliu-Masgoret, M, García-Pardo, G, Marimon-Cortés, F. 01/02/2023. Revista de gastroenterologia de Mexico. 88. PMID: 35783558. doi: 10.1016/j.rgmx.2022.05.006

    IMMUNOPATHOLOGICAL SCENARIOS DEFINING COEXISTENCE BETWEEN SJOGREN SYNDROME AND SARCOIDOSIS

    Flores-Chavez, A, Ng, F, Alunno, A, Inanc, N, Abacar, KY, Feijoo-Masso, C, Seror, R, Hernandez-Molina, G, Hofauer, B, Pasoto, SG, Robles, A, Akasbi, M, Brito-Zerón, P, Lopez-Dupla, M, Retamozo, S, Bandeira, M, Romao, VC, Devauchelle-Pensec, V, Carubbi, F, Mariette, X, Ramos-Casals, M. 01/12/2022. Clinical And Experimental Rheumatology. 40

    KEY FEATURES AT DIAGNOSIS OF PRIMARY SJOGREN SYNDROME IN 15,652 PATIENTS: 2022 SJOGREN BIG DATA PROJECT

    Flores-Chavez, A, Horváth, FI, Li, X, Rasmussen, A, Ng, F, Dong, X, Priori, R, Olsson, P, Baldini, C, Seror, R, Bootsma, H, Armagan, B, Gottenberg, J, Kruize, A, Hernandez-Molina, G, Paprovnik, S, Danda, D, Özkiziltas, B, Inanc, N, Sebastian, A, Bocci, EB, Quartuccio, L, Romao, VC, Rischmueller, M, Suzuki, Y, Kwok, S, Kvarnstrom, M, Solans, R, Pasoto, SG, Galisteo, C, Sene, D, Trevisani, VM, Isenberg, D, Hofauer, B, Shimizu, T, Nordmark, G, Valim, V, Jurcut, C, Carubbi, F, Garcia, AG, Retamozo, S, Devauchelle-Pensec, V, Díaz, SM, Gheita, TA, Brito-Zerón, P, López-Dupla, M, Fonseca-Aizpuru, E, Sánchez-Berná, I, Morel, J, Giacomelli, R, Atzeni, F, Consani, S, Vazquez, M, Akasbi, M. 01/12/2022. Clinical And Experimental Rheumatology. 40

    Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients

    Flores-Chavez, A, Ng, WF, Alunno, A, Inanc, N, Feijoo-Massó, C, Seror, R, Hernandez-Molina, G, Devauchelle-Pensec, V, Hofauer, B, Pasoto, SG, Robles, A, Akasbi, M, López-Dupla, M, Retamozo, S, Bandeira, M, Romao, VC, Carubbi, F, Loaiza-Cabello, D, García-Morillo, JS, Benegas, M, Sánchez, M, Muxí, A, Fuster, D, Sellarés, J, Mariette, X, Ramos-Casals, M, Brito-Zerón, P. 01/12/2022. Clinical And Experimental Rheumatology. 40. PMID: 36541233. doi: 10.55563/clinexprheumatol/pg964c

    SAFETY AND EFFICACY OF SARS-COV-2 VACCINATION IN 1237 PATIENTS WITH PRIMARY SJOGREN SYNDROME

    Inanc, N, Kostov, B, Priori, R, Flores-Chavez, A, Carubbi, F, Szantó, A, Valim, V, Bootsma, H, Praprotnik, S, Trevisani, VFM, Hernández-Molina, G, Hofauer, B, Pasoto, SG, Dupla, ML, Bocci, EB, Rischmueller, M, Devauchelle-Pensec, V, Abacar, KY, Giardina, F, Alunno, A, Horváth, IF, De Wolff, L, Caldas, L, Retamozo, S, Ramos-Casals, M, Brito-Zerón, P. 01/12/2022. Clinical And Experimental Rheumatology. 40

    Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjogren syndrome

    Inanc, N, Kostov, B, Priori, R, Flores-Chavez, A, Carubbi, F, Szántó, A, Valim, V, Bootsma, H, Praprotnik, S, Trevisani, VFM, Hernández-Molina, G, Hofauer, B, Pasoto, SG, López-Dupla, M, Bartoloni, E, Rischmueller, M, Devauchelle-Pensec, V, Abacar, K, Giardina, F, Alunno, A, Horváth, IF, de Wolff, L, Caldas, L, Retamozo, S, Ramos-Casals, M, Brito-Zerón, P. 01/12/2022. Clinical And Experimental Rheumatology. 40. PMID: 36441656

    INFLUENCE OF EPIDEMIOLOGY AND ETHNICITY ON SYSTEMIC EXPRESSION OF PRIMARY SJOGREN SYNDROME AT DIAGNOSIS: WORLDWIDE PATTERNS IN 14,836 PATIENTS (2022 SJOGREN BIG DATA PROJECT)

    Retamozo, S, Szanto, A, Li, X, Rasmussen, A, Ng, F, Dong, X, Priori, R, Olsson, P, Baldini, C, Seror, R, Bootsma, H, Armagan, B, Gottenberg, J, Kruize, A, Hernandez-Molina, G, Paprovnik, S, Danda, D, Özkiziltas, B, Inanc, N, Quartuccio, L, Sebastian, A, Gerli, R, Romao, VC, Rischmueller, M, Suzuki, Y, Kwok, S, Kvarnstrom, M, Solans, R, Pasoto, SG, Galisteo, C, Sene, D, Trevisani, VM, Isenberg, D, Hofauer, B, Shimizu, T, Nordmark, G, Valim, V, Jurcut, C, Carubbi, F, García, AG, Devauchelle-Pensec, D, Díaz, SM, Gheita, TA, Brito-Zerón, P, López-Dupla, M, Fonseca-Aizpuru, E, Sanchez-Berna, I, Morel, J, Giacomelli, R, Atzeni, F, Consani, C, Vázquez, M, Akasbi, M, Flores-Chavez, A, Ramos-Casals, M. 01/12/2022. Clinical And Experimental Rheumatology. 40

    Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.

    Roso-Llorach A, Serra-Picamal X, Cos FX, Pallejà-Millán M, Mateu L, Rosell A, Almirante B, Ferrer J, Gasa M, Gudiol C, Moreno AM, Morales-Rull JL, Rexach M, Sabater G, Auguet T, Vidal F, Lerida A, Rebull J, Khunti K, Argimon JM, Paredes R. 01/12/2022. Global Epidemiology. 4. PMID: 35018339. doi: 10.1016/j.gloepi.2022.100071

    Effects of advanced HIV disease on inflammation following ART initiation

    Bisbal, O, Serrano-Villar, S, Domínguez-Domínguez, L, Rava, M, Guitierrez, C, Rull, A, Pérez-LaTorre, L, Gutierrez, F, Saumoy, M, Amador, C, Jarrin, I, Iribarren, J, Rubio, R, Guillén, SM. 01/10/2022. Journal Of The International Aids Society. 25

    Transmitted drug resistance in Spain (CoRIS) patients during 2019 to 2021

    Viñuela, L, Fuentes-López, A, de Salazar, A, Serrano-Conde, E, Perez-Elias, M, Olalla, J, Arce-García, O, Iribarren, J, Masiá, M, Montero-Alonso, M, Falces-Romero, I, Blanco, J, Rivero, M, Fraile, LG, Aguilera, NE, Baza, B, Aguilera, A, Maciá, M, Martínez-Velasco, M, Iborra, A, Imaz, A, Lirola, AL, Peraire, J, Portilla, I, Rando, A, Suárez-García, I, Izquierdo, R, Garcia, F. 01/10/2022. Journal Of The International Aids Society. 25

    Cross-cultural adaptation of the SCORE survey and evaluation of the impact of Real-Time Random Safety Audits in organizational culture: A multicenter study

    Sirgo, G, Olona, M, Martín-Delgado, MC, Gordo, F, Trenado, J, García, M, Bodí, M. 01/10/2022. Medicina Intensiva. 46. PMID: 34052044. doi: 10.1016/j.medin.2021.03.015

    Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

    Ceperuelo-Mallafré, V, Reverté, L, Peraire, J, Madeira, A, Maymó-Masip, E, López-Dupla, M, Gutierrez-Valencia, A, Ruiz-Mateos, E, Buzón, MJ, Jorba, R, Vendrell, J, Auguet, T, Olona, M, Vidal, F, Rull, A, Fernández-Veledo, S. 14/09/2022. Frontiers in immunology. 13. PMID: 36189213. doi: 10.3389/fimmu.2022.912579

    Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    Alvarez, H, Rava, M, Martínez, C, Portilla, J, Peraire, J, Rivero, A, Cervero, M, Mariño, A, Poveda, E, Llibre, JM. 01/09/2022. Hiv Medicine. 23. PMID: 35234328. doi: 10.1111/hiv.13265

    Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019)

    Badia-Cebada, L, Peñafiel, J, López-Contreras, J, Pomar, V, Martínez, JA, Santana, G, Cuquet, J, Montero, MM, Hidalgo-López, C, Andrés, M, Gimenez, M, Quesada, MD, Vaqué, M, Iftimie, S, Gudiol, C, Pérez, R, Coloma, A, Marron, A, Barrufet, P, Marimon, M, Lérida, A, Clarós, M, Ramírez-Hidalgo, MF, Pardo, GG, Martinez, MJ, Chamarro, EL, Jiménez-Martínez, E, Hornero, A, Limón, E, López, M, Calbo, E, Pujol, M, Gasch, O. 01/08/2022. Journal Of Hospital Infection. 126. PMID: 35594988. doi: 10.1016/j.jhin.2022.05.009

    Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation

    Masip, J, Jorba, R, López-Dupla, M, Domingo, P, Pacheco, YM, García-Pardo, G, Martínez, E, Viladés, C, Veloso, S, Alba, V, Olona, M, Vidal, F, Gómez-Bertomeu, F, Peraire, J, Rull, A. 01/08/2022. International Journal Of Molecular Sciences. 23. PMID: 35897644. doi: 10.3390/ijms23158071

    Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

    Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Téllez, MJ, Domínguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Román, A, Santos, I, Giner, L, Armiñanzas, C, Montero, M, Manzardo, C, Cifuentes, C, García, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodríguez, C, Gaspar, G, Pérez, L, Losa, JE, Force, L, Veloso, S, Martínez-Alfaro, E, Jarrín, I, De Miguel, M, Garcia, JG. 01/08/2022. Hiv Medicine. 23. PMID: 35037379. doi: 10.1111/hiv.13229

    Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

    Trujillo-Rodriguez, M, Muñoz-Muela, E, Serna-Gallego, A, Praena-Fernández, JM, Pérez-Gómez, A, Gasca-Capote, C, Vitallé, J, Peraire, J, Palacios-Baena, ZR, Cabrera, JJ, Ruiz-Mateos, E, Poveda, E, López-Cortés, LE, Rull, A, Gutierrez-Valencia, A, López-Cortés, LF. 14/07/2022. Plos One. 17. PMID: 35834501. doi: 10.1371/journal.pone.0269875

    Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

    Teira, R, Diaz-Cuervo, H, Aragao, F, Castaño, M, Romero, A, Roca, B, Montero, M, Galindo, MJ, Muñoz-Sánchez, MJ, Espinosa, N, Peraire, J, Martínez, E, De la Fuente, B, Domingo, P, Deig, E, Merino, MD, Geijo, P, Estrada, V, Sepúlveda, MA, García, J, Berenguer, J, Currán, A. 01/06/2022. Infectious Diseases And Therapy. 11. PMID: 35399147. doi: 10.1007/s40121-022-00630-y

    Elevated a-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control.

    Masip J, Rallón N, Yeregui E, Olona M, Resino S, Benito JM, Viladés C, García-Pardo G, Alcamí J, Ruiz-Mateos E, Gómez-Bertomeu F, Vargas M, Navarro M, Oteo JA, Pineda JA, Martí A, Alba V, Vidal F, Peraire J, Rull A. 20/04/2022. Frontiers in immunology. 13. PMID: 35514981. doi: 10.3389/fimmu.2022.822272

    Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

    Martin-Vicente, M, Berenguer, J, Muñoz-Gómez, MJ, Díez, C, Micán, R, Pérez-Elías, MJ, García-Fraile, LJ, Peraire, J, Suárez-García, I, Jiménez-Sousa, MA, Fernández-Rodríguez, A, Vázquez, M, Ryan, P, González-García, J, Jarrín, I, Mas, V, Martínez, I, Resino, S. 01/03/2022. Journal Of Infection. 84. PMID: 34752819. doi: 10.1016/j.jinf.2021.11.002

    Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome

    Perpiñan, C, Bertran, L, Terra, X, Aguilar, C, Binetti, J, Lopez-Dupla, M, Rull, A, Reverté, L, Yeregui, E, Gómez-Bertomeu, F, Peraire, J, Auguet, T. 01/03/2022. Journal of personalized medicine. 12. PMID: 35330391. doi: 10.3390/jpm12030391

    Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

    Yeregui, E, Masip, J, Viladés, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, García-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Martí, A, Reverté, L, Gómez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. 01/02/2022. International Journal Of Molecular Sciences. 23. PMID: 35216318. doi: 10.3390/ijms23042202

    Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy

    Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. 01/02/2022. Journal of clinical medicine. 11. PMID: 35160008. doi: 10.3390/jcm11030549

    DBP rs7041 and DHCR7 rs3829251 are Linked to CD4+ Recovery in HIV Patients on Antiretroviral Therapy

    Resino, S, Jimenez-Sousa, MA, Blanco, J, Pacheco, YM, del Romero, J, Peraire, J, Virseda-Berdices, A, Munoz-Gomez, MJ, Galera-Penaranda, C, Garcia-Fraile, LJ, Benito, JM, Rallon, N. 18/01/2022. Frontiers in Pharmacology. 12. PMID: 35115928. doi: 10.3389/fphar.2021.773848

    Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes

    Auguet, T, Lopez-Dupla, M, Ramos, J, Bertran, L, Riesco, D, Aguilar, C, Ardévol, A, Pinent, M, Sabench, F, Del Castillo, D, Richart, C. 01/01/2022. Processes. 10. doi: 10.3390/pr10010143

    Fetuin-A, inter-a-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

    Reverté, L, Yeregui, E, Olona, M, Gutiérrez-Valencia, A, Buzón, MJ, Martí, A, Gómez-Bertomeu, F, Auguet, T, López-Cortés, LF, Burgos, J, Benavent-Bofill, C, Boqué, C, García-Pardo, G, Ruiz-Mateos, E, Mestre, MT, Vidal, F, Viladés, C, Peraire, J, Rull, A. 01/01/2022. Clinical And Translational Medicine. 12. PMID: 35075803. doi: 10.1002/ctm2.704

    Cross-cultural adaptation of the SCORE survey and evaluation of the impact of Real-Time Random Safety Audits in organizational culture: A multicenter study.

    Sirgo G, Olona M, Martín-Delgado MC, Gordo F, Trenado J, García M, Bodí M. 01/10/2022. Medicina Intensiva. 46. PMID: 36155679. doi: 10.1016/j.medine.2021.03.005

Membres De L’equip

  • Responsables de grupo

    • Dr. Joaquim Peraire Forner
    • Dra. Anna Rull Aixa
  • EQUIPO DE INVESTIGACIÓN

    • Alba Sánchez Morillo
    • Anna Martí Gil
    • Beatriz Prieto Simón
    • Beatriz Villar Navas
    • Clara Franco Jarava
    • Consuelo Viladés Laborda
    • Francesc Vidal Marsal
    • Frederic Gómez Bertomeu
    • Graciano García-Pardo
    • Lluïsa Guillem Tió
    • Miguel López Dupla
    • Marina Flores Piñas
    • Sergi Veloso Esteban
    • Silvia Briansó
    • Silvia Chafino Aixa
    • Sonia Espineira Vazquez
    • Verónica Alba Elvira